Literature DB >> 27155327

Livedoid vasculopathy - a challenging disease.

R Vieira, J M Bernardes, J A Pinto, L Costa.   

Abstract

We present a rare association of idiopathic livedoid vasculopathy (LV) with peripheral sensory neuropathy successfully treated with intravenous immunoglobulin and warfarin and, after its failure, with rituximab. Although LV aetiology remains incompletely understood, the excellent clinical response observed in our patient suggests that B cells may be key players in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27155327

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  3 in total

Review 1.  Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.

Authors:  Yimeng Gao; Hongzhong Jin
Journal:  Ther Adv Chronic Dis       Date:  2022-05-22       Impact factor: 4.970

Review 2.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

3.  Use of Low-dose Oral Warfarin in Three Cases of Livedoid Vasculopathy.

Authors:  Vikrant Saoji; Bhushan Madke
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.